CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00590642
NCT00590642N/ACompleted
CompareCT.gov

Augment in Treatment-resistent Obsessive-compulsive Disorder: an Open-label Trial

Creighton University·observational·Posted Jan 10, 2008·Updated Dec 1, 2009

In Brief

An observational study for Obsessive Compulsive Disorder. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study examines the use of Acamprosate (Campral(R)) in the treatment of Obsessive Compulsive Disorder (OCD). The treatment of this condition is difficulty and a large percentage of patients fail to respond to medications and have residual symptoms. Such patients are referred to as having treatment resistant OCD.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsObsessive Compulsive Disorder
CountriesUnited States
CollaboratorsForest Laboratories

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 10, 2008
Enrollment StartApr 1, 2006
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 18.5 years ago